Literature DB >> 15604436

Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France.

Florence Nicot1, Florence Legrand-Abravanel1, Karine Sandres-Saune1, Anne Boulestin1, Martine Dubois1, Laurent Alric2, Jean-Pierre Vinel3, Christophe Pasquier1, Jacques Izopet1.   

Abstract

Hepatitis C virus (HCV) is a major cause of liver disease. Knowledge of HCV variability is crucial for clinical and epidemiological analysis. HCV genotype 4 (HCV-4) has become increasingly prevalent in European countries, including France, in recent years. The present study investigates the heterogeneity of HCV-4 in south-western France by phylogenetic analysis of NS5B sequences from 166 patients. The E2 region of 90 strains was also analysed. Genotype 4 accounts for 7.4 % of HCV infections in this area. Analysis of the NS5B region revealed 12 subtypes and the NS5B and E2 phylogeny data were congruent, except for one strain. The epidemiological data indicated two main groups of patients. One included intravenous drug users (IVDUs) of French origin, who were infected by homogeneous strains of subtypes 4a or 4d. The second group comprised non-IVDU patients who were infected with heterogeneous strains. This group was subdivided into patients of French origin, who were infected with eight subtypes, and patients from non-European countries (Central Africa or the Middle East), who were mainly infected with 4f, 4k, 4r and other subtypes; they showed the greatest genetic heterogeneity. This study of a large cohort of patients shows the great diversity of HCV-4 strains, and that these subtypes have spread differently.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15604436     DOI: 10.1099/vir.0.80409-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  16 in total

1.  Treatment of genotype 4 hepatitis C recurring after liver transplantation using a combination of pegylated interferon alfa-2a and ribavirin.

Authors:  Waleed Al-Hamoudi; Hazem Mohamed; Faisal Abaalkhail; Yaser Kamel; Nasser Al-Masri; Naglaa Allam; Saleh Alqahtani; Mohammed Al-Sofayan; Hatem Khalaf; Mohammed Al-Sebayel; Ahmed Al-Jedai; Ayman Abdo
Journal:  Dig Dis Sci       Date:  2011-01-08       Impact factor: 3.199

2.  Complete genomic sequences for hepatitis C virus subtypes 4b, 4c, 4d, 4g, 4k, 4l, 4m, 4n, 4o, 4p, 4q, 4r and 4t.

Authors:  Chunhua Li; Ling Lu; Xianghong Wu; Chuanxi Wang; Phil Bennett; Teng Lu; Donald Murphy
Journal:  J Gen Virol       Date:  2009-04-08       Impact factor: 3.891

3.  Emergence of hepatitis C virus genotype 4: phylogenetic analysis reveals three distinct epidemiological profiles.

Authors:  Joep de Bruijne; Janke Schinkel; Maria Prins; Sylvie M Koekkoek; Sem J Aronson; Marijn W van Ballegooijen; Hendrik W Reesink; Richard Molenkamp; Thijs J W van de Laar
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

4.  Epidemiological features of patients infected with HCV genotype 4 in Poland: Epidemiology of HCV genotype 4 in Poland.

Authors:  Slawomir Chlabicz; Robert Flisiak; Tadeusz W Lapinski; Oksana Kowalczuk; Alicja Wiercinska-Drapalo; Barbara Pytel-Krolczuk; Anna Grzeszczuk; Lech Chyczewski; Joanna Pancewicz
Journal:  Hepat Mon       Date:  2011-03       Impact factor: 0.660

5.  European vs. Egyptian HCV-4 patients with elevated baseline HCV RNA, treated with PEG-IFN-α2a and ribavirin: the role of rapid and early virologic response.

Authors:  Dimitrios Dimitroulopoulos; Ioannis Elefsiniotis; Christos Pavlidis; Dimitrios Xinopoulos; Klisthenis Tsamakidis; Stamatina Patsavela; Dimitrios Kypreos; Ageliki Ferderigou; Dimitrios Korkolis; Sotirios Koutsounas; Georgios Saroglou; Emmanouil Paraskevas
Journal:  Hepat Mon       Date:  2010-09-01       Impact factor: 0.660

6.  Molecular epidemiology of hepatitis C infection in Cyprus within the general population and high-risk cohorts.

Authors:  Victoria L Demetriou; Leondios G Kostrikis
Journal:  BMC Res Notes       Date:  2011-10-31

7.  Hepatitis C virus genotyping using an oligonucleotide microarray based on the NS5B sequence.

Authors:  Dimitry Gryadunov; Florence Nicot; Martine Dubois; Vladimir Mikhailovich; Alexander Zasedatelev; Jacques Izopet
Journal:  J Clin Microbiol       Date:  2010-09-15       Impact factor: 5.948

8.  Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5' untranslated region sequences.

Authors:  Donald G Murphy; Bernard Willems; Marc Deschênes; Nir Hilzenrat; Roger Mousseau; Sidney Sabbah
Journal:  J Clin Microbiol       Date:  2007-02-07       Impact factor: 5.948

9.  Phylogenetic analysis of isolated HCV strains from tunisian hemodialysis patients.

Authors:  Fatma Houissa Kchouk; Yousr Gorgi; Lamjed Bouslama; Imen Sfar; Rym Ayari; Hacene Khiri; Phillipe Halfon; Houda Aouadi; Saloua Jendoubi Ayed; Khaled Ayed; Taieb Ben Abdallah
Journal:  Viral Immunol       Date:  2013-02-01       Impact factor: 2.257

10.  Hepatitis C genotype 4: genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia.

Authors:  Hamad I Al Ashgar; Mohammed Q Khan; Mohammed Al-Ahdal; Sahar Al Thawadi; Ahmad Salem Helmy; Ahmed Al Qahtani; Faisal M Sanai
Journal:  Saudi J Gastroenterol       Date:  2013 Jan-Feb       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.